Multi-omics personalized network analyses highlight progressive disruption of central metabolism associated with COVID-19 severity.

COVID-19 personalized genome-scale metabolic model similarity network fusion

Journal

Cell systems
ISSN: 2405-4720
Titre abrégé: Cell Syst
Pays: United States
ID NLM: 101656080

Informations de publication

Date de publication:
17 08 2022
Historique:
received: 08 12 2021
revised: 18 04 2022
accepted: 27 06 2022
pubmed: 8 8 2022
medline: 23 8 2022
entrez: 7 8 2022
Statut: ppublish

Résumé

The clinical outcome and disease severity in coronavirus disease 2019 (COVID-19) are heterogeneous, and the progression or fatality of the disease cannot be explained by a single factor like age or comorbidities. In this study, we used system-wide network-based system biology analysis using whole blood RNA sequencing, immunophenotyping by flow cytometry, plasma metabolomics, and single-cell-type metabolomics of monocytes to identify the potential determinants of COVID-19 severity at personalized and group levels. Digital cell quantification and immunophenotyping of the mononuclear phagocytes indicated a substantial role in coordinating the immune cells that mediate COVID-19 severity. Stratum-specific and personalized genome-scale metabolic modeling indicated monocarboxylate transporter family genes (e.g., SLC16A6), nucleoside transporter genes (e.g., SLC29A1), and metabolites such as α-ketoglutarate, succinate, malate, and butyrate could play a crucial role in COVID-19 severity. Metabolic perturbations targeting the central metabolic pathway (TCA cycle) can be an alternate treatment strategy in severe COVID-19.

Identifiants

pubmed: 35933992
pii: S2405-4712(22)00276-9
doi: 10.1016/j.cels.2022.06.006
pmc: PMC9263811
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

665-681.e4

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Références

Nat Methods. 2014 Mar;11(3):333-7
pubmed: 24464287
J Biol Chem. 2022 Apr;298(4):101800
pubmed: 35257743
J Infect Dis. 2020 Aug 17;222(6):894-898
pubmed: 32582936
Nucleic Acids Res. 2013 Apr;41(8):4378-91
pubmed: 23444143
Crit Rev Immunol. 2012;32(2):139-55
pubmed: 23216612
Pharmacol Rev. 2020 Jan;72(1):343-379
pubmed: 31882442
Life Sci Alliance. 2022 May 10;5(9):
pubmed: 35537851
Annu Rev Nutr. 2017 Aug 21;37:51-76
pubmed: 28826372
Life Sci Alliance. 2021 Aug 5;4(10):
pubmed: 34353886
Sci Rep. 2021 Jul 1;11(1):13637
pubmed: 34211032
Int J Infect Dis. 2021 Feb;103:25-32
pubmed: 33186704
J Cell Mol Med. 2020 Oct;24(19):11603-11606
pubmed: 32864865
Immun Ageing. 2019 Jan 26;16:3
pubmed: 30700992
Mol Syst Biol. 2014 Mar 19;10:721
pubmed: 24646661
Sci Signal. 2020 Mar 24;13(624):
pubmed: 32209698
Proc Natl Acad Sci U S A. 2014 Feb 11;111(6):2247-52
pubmed: 24390544
Front Immunol. 2021 Jun 28;12:700782
pubmed: 34262570
Adv Nutr. 2018 Jan 1;9(1):21-29
pubmed: 29438462
Nat Commun. 2021 Jul 5;12(1):4117
pubmed: 34226537
Mol Cell Proteomics. 2021;20:100159
pubmed: 34619366
BMC Bioinformatics. 2013 Apr 15;14:128
pubmed: 23586463
Nat Med. 2020 Jun;26(6):842-844
pubmed: 32398875
PLoS Comput Biol. 2012;8(5):e1002518
pubmed: 22615553
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Mucosal Immunol. 2022 Mar;15(3):515-524
pubmed: 35288643
Front Immunol. 2021 Jul 30;12:700152
pubmed: 34394094
Database (Oxford). 2019 Jan 1;2019:
pubmed: 30951143
Mol Syst Biol. 2009;5:323
pubmed: 19888218
J R Soc Interface. 2018 Sep 12;15(146):
pubmed: 30209043
Emerg Microbes Infect. 2020 Dec;9(1):1748-1760
pubmed: 32691695
Methods Mol Biol. 2020;2120:233-248
pubmed: 32124324
Proc Natl Acad Sci U S A. 2021 Feb 9;118(6):
pubmed: 33479167
Bioinformatics. 2020 Dec 30;36(Suppl 2):i813-i821
pubmed: 33381848
Science. 2017 Apr 21;356(6335):
pubmed: 28428369
Comput Struct Biotechnol J. 2021;19:976-988
pubmed: 33558827
Mol Aspects Med. 2013 Apr-Jun;34(2-3):337-49
pubmed: 23506875
Front Immunol. 2021 Jun 23;12:691725
pubmed: 34248984
Nat Protoc. 2019 Mar;14(3):639-702
pubmed: 30787451
J Mol Cell Biol. 2019 Jan 1;11(1):1-13
pubmed: 30239845
Mol Syst Biol. 2020 May;16(5):e8982
pubmed: 32463598
Front Pharmacol. 2021 Feb 04;11:600369
pubmed: 33613280
Trends Microbiol. 2011 Jul;19(7):360-7
pubmed: 21570293
PLoS Pathog. 2021 Jul 6;17(7):e1009721
pubmed: 34228753
FEBS Lett. 2021 Sep;595(18):2350-2365
pubmed: 34409594
Microbiol Spectr. 2021 Oct 31;9(2):e0054921
pubmed: 34468185
Anal Biochem. 2004 Aug 15;331(2):283-95
pubmed: 15265734
Bioinformatics. 2016 Sep 15;32(18):2847-9
pubmed: 27207943
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Nucleic Acids Res. 2019 Jan 8;47(D1):D721-D728
pubmed: 30289549
JCI Insight. 2020 Jul 23;5(14):
pubmed: 32559180
Science. 2017 Aug 18;357(6352):
pubmed: 28818916
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Natl Sci Rev. 2020 Jul;7(7):1157-1168
pubmed: 34676128
Cell Death Differ. 2020 Nov;27(11):3196-3207
pubmed: 32514047
Am J Physiol Lung Cell Mol Physiol. 2013 Nov 15;305(10):L702-11
pubmed: 24056971
Scand J Immunol. 2022 Jan;95(1):e13108
pubmed: 34625989
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Cell Metab. 2020 Sep 1;32(3):498-499
pubmed: 32877692
EMBO J. 2020 Dec 15;39(24):e105896
pubmed: 33140861
Front Immunol. 2021 Mar 25;12:652470
pubmed: 33841435
J Clin Invest. 2021 Mar 15;131(6):
pubmed: 33492309
PLoS Comput Biol. 2018 Oct 18;14(10):e1006541
pubmed: 30335785
Proc Natl Acad Sci U S A. 2018 Sep 18;115(38):E8929-E8938
pubmed: 30181265
Sci Rep. 2019 Mar 26;9(1):5233
pubmed: 30914743
Proc Natl Acad Sci U S A. 2021 Oct 5;118(40):
pubmed: 34548411
Front Immunol. 2021 May 24;12:665773
pubmed: 34108966
Cell. 2020 Sep 17;182(6):1419-1440.e23
pubmed: 32810438
JCI Insight. 2020 Jun 4;5(11):
pubmed: 32329756
Biomed Pharmacother. 2021 Dec;144:112346
pubmed: 34678727
Front Immunol. 2019 Dec 13;10:2759
pubmed: 31921102
Nat Biotechnol. 2020 Aug;38(8):970-979
pubmed: 32591762
Nat Cell Biol. 2021 May;23(5):538-551
pubmed: 33972731
Nat Biotechnol. 2014 Sep;32(9):896-902
pubmed: 25150836
Cell Host Microbe. 2020 Jun 10;27(6):992-1000.e3
pubmed: 32320677
Gut Microbes. 2022 Jan-Dec;14(1):2073131
pubmed: 35574937
Nature. 2021 Jul;595(7865):107-113
pubmed: 33915569
Virol J. 2019 Oct 29;16(1):124
pubmed: 31665046
Cell. 2020 Jul 9;182(1):59-72.e15
pubmed: 32492406
Circ Cardiovasc Genet. 2012 Feb 1;5(1):7-9
pubmed: 22337925
BMC Bioinformatics. 2011 Jan 26;12:35
pubmed: 21269502
Sci Immunol. 2020 Sep 28;5(51):
pubmed: 32989174
Nat Immunol. 2020 Sep;21(9):1107-1118
pubmed: 32788748

Auteurs

Anoop T Ambikan (AT)

The Systems Virology Laboratory, Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, 141 52 Stockholm, Sweden.

Hong Yang (H)

Science for Life Laboratory, KTH-Royal Institute of Technology, Stockholm, Sweden.

Shuba Krishnan (S)

The Systems Virology Laboratory, Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, 141 52 Stockholm, Sweden.

Sara Svensson Akusjärvi (S)

The Systems Virology Laboratory, Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, 141 52 Stockholm, Sweden.

Soham Gupta (S)

The Systems Virology Laboratory, Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, 141 52 Stockholm, Sweden.

Magda Lourda (M)

Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, 141 52 Stockholm, Sweden; Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, 171 77 Stockholm, Sweden.

Maike Sperk (M)

The Systems Virology Laboratory, Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, 141 52 Stockholm, Sweden.

Muhammad Arif (M)

Science for Life Laboratory, KTH-Royal Institute of Technology, Stockholm, Sweden.

Cheng Zhang (C)

Science for Life Laboratory, KTH-Royal Institute of Technology, Stockholm, Sweden.

Hampus Nordqvist (H)

Södersjukhuset (The South General Hospital), 118 83 Stockholm, Sweden.

Sivasankaran Munusamy Ponnan (SM)

HIV Vaccine Trials Network, Vaccine and Infectious Disease, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, WA 98109, USA.

Anders Sönnerborg (A)

Department of Medicine Huddinge, Division of Infectious Diseases, Karolinska Institute, I73, Karolinska University Hospital, Huddinge, 141 86 Stockholm, Sweden; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, ANA Futura, Campus Flemingsberg, 141 52 Stockholm, Sweden.

Carl Johan Treutiger (CJ)

Södersjukhuset (The South General Hospital), 118 83 Stockholm, Sweden; Department of Medicine Huddinge, Division of Infectious Diseases, Karolinska Institute, I73, Karolinska University Hospital, Huddinge, 141 86 Stockholm, Sweden.

Liam O'Mahony (L)

School of Microbiology, University College Cork, National University of Ireland, T12 YN60 Cork, Ireland; APC Microbiome Ireland, University College Cork, National University of Ireland, T12 YN60 Cork, Ireland; Department of Medicine, University College Cork, National University of Ireland, T12 YN60 Cork, Ireland.

Adil Mardinoglu (A)

Science for Life Laboratory, KTH-Royal Institute of Technology, Stockholm, Sweden; Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London WC2R 2LS London, UK.

Rui Benfeitas (R)

National Bioinformatics Infrastructure Sweden (NBIS), Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, 106 91 Stockholm, Sweden.

Ujjwal Neogi (U)

The Systems Virology Laboratory, Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, 141 52 Stockholm, Sweden; Manipal Institute of Virology (MIV), Manipal Academy of Higher Education, Manipal, 576104 Karnataka, India. Electronic address: ujjwal.neogi@ki.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH